Atlas FDA

PROGENSA PCA3 ASSAY

FDA premarket approval P100033/S003 · decided 2015-04-16

Approval details

PMA number
P100033
Supplement
S003
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PROGENSA PCA3 ASSAY
Generic name
Prostrate cancer genes nucleic acid amplification test system
Applicant
Gen-Probe Incorporated
Date received
2015-03-19
Decision date
2015-04-16
Days to decision
28 days
Decision code
OK30
Product code
OYM
Advisory committee
Pathology
Expedited review
No
Location
San Diego, CA
Statement
MANUFACTURING SCALE UP OF BULK ENZYME RECONSTITUTION SOLUTION (P/N BS0421), BY ALLOWING BULKING AND FILLING FROM LARGER TANKS (208L AND 303L) AND ADDITIONALLY, TOEXTEND THE BULK HOLD TIME FROM 7 DAYS UP TO 1 MONTH TO ALLOW SUFFICIENT TIME FOR THE SOLUTION TO BE USED WITHIN MANUFACTURING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012)Gen-Probe Incorporated2011-04-19